ARCHIVES

FDA Approves Erbitux for Head & Neck Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 08 | March 3, 2006

Download PDF Visit The Full Archive

Related Articles

The First BRCA1 Test Hits The Market; Are Oncologists, Patients Ready?

January 26, 1996

Golde To Step Down At MSK; Porter Joins Hogan & Hartson.

January 26, 2001

New Community Clinical Oncology Programs Aimed At Three Hospital Types; 30 Contracts Possible

November 24, 1978

USLA’’s Steckel Asks More Centers Staff, Strict Enforcement of Guidelines

February 17, 1978

Cancer research poised for a “platinum age” as a “golden age” ends, NCI director tells AACR annual meeting.

April 29, 2005

U. S. Oncologists To Audit Another Bezwoda Trial.

November 10, 2000